33 reports

Source: Cowen and Company, company documents ##% ##% ##% ##% ##% Zimmer Biomet Stryker Corporation Wright medical Exactech J& J Others ##. ##. ## OUTSIDE THE U. S.

  • Orthopedics
  • United States
  • World
  • Integra LifeSciences Holdings Corporation
  • MicroPort Scientific Corporation

Healthcare is one of the most regulated industries in the United States.

  • Orthopedics
  • United States
  • Medtronic, Inc.
  • NuVasive, Inc.
  • Stryker Corporation
  • MARKET SIZE AND FORECAST 2017-2022

You can easily book an appointment with one online.

  • Orthopedics
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • NuVasive, Inc.
  • Stryker Corporation
  • 6.1 INTRODUCTION
  • Bone Graft Substitutes

IN THE LONG TERM, ADVANCEMENTS IN TISSUE ENGINEERING AND GENE THERAPY WILL PLAY A CRUCIAL ROLE IN DRIVING THE SPINE BIOLOGICS MARKET.

  • Orthopedics
  • Exactech, Inc.
  • Medtronic, Inc.
  • NuVasive, Inc.
  • Stryker Corporation

ABOUT THE ADVANCE PHASE ##/ ## CLINICAL TRIAL OF ADVM-## FOR A##AT DEFICIENCY ADVM-## (AAVRH. ##-A##AT) IS A GENE THERAPY CANDIDATE DESIGNED AS A POTENTIAL SINGLE-ADMINISTRATION TREATMENT TO INDUCE STABLE, LONG-TERM A##AT PROTEIN EXPRESSION.

  • Orthopedics
  • Germany
  • Western Europe
  • Market Size
  • Stryker Corporation

Others** include cancer, dialysis, drug delivery systems, and gene therapy ##.

  • Orthopedics
  • North America
  • United States
  • Market Size
  • Kyocera Corporation

One such body is CIHR (Canadian Institutes of Health Research), which, in collaboration with health research organizations, supports research in the areas of gene therapy, stem cells, and tissue engineering.

  • Orthopedics
  • North America
  • United States
  • Market Size
  • Arthrex, Inc.
  • ES-1 PRESENTS THE VARIOUS TYPES OF BIORESORBABLE FIXATION DEVICES UTILIZED IN ORTHOPEDIC/SPORTS MEDICINE APPLICATIONS.
  • ES-3 PRESENTS THE U.S. MARKET FORECAST FOR VISCOSUPPLEMENTATION PRODUCTS FOR THE YEARS 2012 THROUGH 2017.

Chapter ## ##. ## CELL AND GENE THERAPIES GENE THERAPY IS AN EXPERIMENTAL TECHNIQUE THAT IS A PROMISING TREATMENT OPTION FOR LIGAMENT AND TENDON REPAIR AND REGENERATION.

  • Orthopedics
  • United States
  • Arthrex, Inc.
  • Biomet, Inc.
  • Smith & Nephew Plc

One such substitute is bioactive glass.

  • Orthobiologics
  • Orthopedics
  • World
  • Company Financials

WE BELIEVE SUE S EXPERIENCE IN THE GROWING AREA OF CELL AND GENE THERAPIES COMBINED WITH HER EXPERTISE IN THE DEVELOPMENT OF NOVEL GENE THERAPIES MAKE HER AN EXCELLENT CHOICE FOR THE HISTOGENICS BOARD OF DIRECTORS. "

  • Hospital
  • Orthobiologics
  • Orthopedics
  • North America
  • Market Size
  • LIQUID FILLED ANKLE BRACE - PRODUCT STATUS
  • LIQUID FILLED ANKLE BRACE - PRODUCT DESCRIPTION

It conducts research programs in brain related problems, aging problems, oncology, genetics, pathogens and gene therapy, and among others.

  • Clinical Trial
  • Medical Device
  • Orthopedics
  • United States
  • Myomo, Inc.

WE BELIEVE SUE S EXPERIENCE IN THE GROWING AREA OF CELL AND GENE THERAPIES COMBINED WITH HER EXPERTISE IN THE DEVELOPMENT OF NOVEL GENE THERAPIES MAKE HER AN EXCELLENT CHOICE FOR THE HISTOGENICS BOARD OF DIRECTORS. "

  • Orthopedics
  • North America
  • Company Financials
  • Demand
  • Zimmer Biomet Holdings, Inc.

We believe Sue s experience in the growing area of cell and gene therapies combined with her expertise in the development of novel gene therapies make her an excellent choice for the Histogenics Board of Directors. "

  • Orthobiologics
  • Orthopedics
  • Pharmaceutical
  • Prosthesis
  • Therapy

We believe Sue s experience in the growing area of cell and gene therapies combined with her expertise in the development of novel gene therapies make her an excellent choice for the Histogenics Board of Directors. "

  • Orthopedic Prosthesis
  • Orthopedics
  • Specialty Hospital
  • United States
  • Histogenics Corporation

ABOUT THE ADVANCE PHASE ##/ ## CLINICAL TRIAL OF ADVM-## FOR A##AT DEFICIENCY ADVM-## (AAVRH. ##-A##AT) IS A GENE THERAPY CANDIDATE DESIGNED AS A POTENTIAL SINGLE-ADMINISTRATION TREATMENT TO INDUCE STABLE, LONG-TERM A##AT PROTEIN EXPRESSION.

  • Orthopedics
  • Southern Europe
  • Western Europe
  • Market Size
  • Collagen Solutions plc
  • OSTEORATE - PRODUCT STATUS

It develops manufacturing process and technology platforms for cardiovascular disease, wound healing and tissue engineering based on its core gene therapy.

  • Drug Development
  • Orthopedics
  • United States
  • Company
  • Anika Therapeutics, Inc.
  • SPACER BLOCK WITH SENSOR - PRODUCT STATUS
  • SPACER BLOCK WITH SENSOR - PRODUCT DESCRIPTION

It conducts research programs in brain related problems, aging problems, oncology, genetics, pathogens and gene therapy, and among others.

  • Orthopedics
  • Prosthesis
  • United States
  • Company
  • Company Financials

ONE UNIT IS ONE IMPLANT SET.

  • Orthopedics
  • East Asia
  • Japan
  • Market Size
  • DePuy Synthes, Inc.

ATMPs comprise gene therapy medicinal products, somatic cell therapy products (as defined in Directive 2001/ ##/ EC), and tissue-engineered products.

  • Medical Biotechnology
  • Orthopedics
  • North America
  • United States
  • MediPost Co., Ltd.

One unit refers to one bone pin.

  • Clinical Trial
  • Medical Textile
  • Orthopedics
  • United States
  • Implantate AG
  • LIQUID FILLED ANKLE BRACE - PRODUCT STATUS
  • UNIVERSITY OF FLORIDA PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW

The institute conducts research in brain related problems, aging problems, oncology, genetics, pathogens and gene therapy, among others.

  • Clinical Trial
  • Home Furnishing
  • Hospital
  • Orthopedics
  • Myomo, Inc.

This act is also known as securing quality, efficacy, and safety of pharmaceuticals, medical devices, regenerative and cellular therapy products, gene therapy products, and cosmetics.

  • Adhesive
  • Orthopedics
  • North America
  • United States
  • Market Size

About the ADVANCE Phase ##/ ## Clinical Trial of ADVM-## for A##AT deficiency ADVM-## (AAVrh. ##-A##AT) is a gene therapy candidate designed as a potential single-administration treatment to induce stable, long-term A##AT protein expression.

  • Orthopedics
  • Germany
  • Company
  • Market Size
  • Medtronic, Inc.
  • GLOBAL TRAUMA FIXATION DEVICES MARKET: DRIVERS AND INHIBITORS

This company is one of the leading orthopedic medical device companies in the world.

  • Orthopedics
  • World
  • Demand
  • Forecast
  • Zimmer Biomet Holdings, Inc.
  • SPACER BLOCK WITH SENSOR - PRODUCT DESCRIPTION
  • SPACER BLOCK WITH SENSOR - PRODUCT STATUS

The institute conducts research in brain related problems, aging problems, oncology, genetics, pathogens and gene therapy, among others.

  • Hospital
  • Medical Device
  • Orthopedics
  • Prosthesis
  • Exactech, Inc.
  • GLOBAL TRAUMA FIXATION DEVICES MARKET: DRIVERS AND INHIBITORS

This company is one of the leading orthopedic medical device companies in the world.

  • Orthopedics
  • World
  • Demand
  • Market Size
  • Zimmer Biomet Holdings, Inc.

In the long term, advancements in tissue engineering and gene therapy will play a crucial role in driving the spine biologics market.

  • Orthopedics
  • Surgical Equipment
  • North America
  • Market Size
  • Medtronic, Inc.

In the long term, advancements in tissue engineering and gene-therapy will play a crucial role in driving the spine biologics market.

  • Orthopedics
  • East Asia
  • United States
  • Market Size
  • Medtronic, Inc.

This company is one of the leading orthopedic medical devices companies in the world.

  • Health Services
  • Orthopedics
  • Europe
  • World
  • Demand
  • EUROPE INTERNAL TRAUMA FIXATION DEVICES MARKET: DRIVERS AND

In addition, tissue engineering and gene therapy techniques are going to add potential customers looking for preventive, rather than curative measures.

  • Orthopedics
  • Europe
  • World
  • Demand
  • Market Size